In vivo axonal transport deficits in a mouse model of fronto-temporal dementia

NeuroImage: Clinical

Volumn 4, Issue , 2014, Pages 711-717

  Majid, Tabassum ^a   Ali, Yousuf O ^a,b   Venkitaramani, Deepa V ^c   Jang, Ming Kuei ^c   Lu, Hui Chen ^a,b   Pautler, Robia G ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Alzheimer's disease; Axonal transport; Fronto temporal dementia; MEMRI; MRI; Tau

Indexed keywords

CARISOPRODOL; MANGANESE CHLORIDE; TAU PROTEIN; WATER; GLIAL FIBRILLARY ACIDIC PROTEIN; MAPT PROTEIN, HUMAN; OLFACTORY MARKER PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; CLINICAL PROTOCOL; COGNITIVE DEFECT; COMPUTER PROGRAM; CONTROLLED STUDY; FOREBRAIN; FRONTOTEMPORAL DEMENTIA; HEATING; IMAGING; IN VIVO STUDY; MOUSE; NERVE DEGENERATION; NERVE FIBER TRANSPORT; NEUROFIBRILLARY TANGLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTORY EPITHELIUM; PHANTOM; PRIORITY JOURNAL; PRISM; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; SPECIES; TAUOPATHY; FEMALE; GENOTYPE; HUMAN; MALE; MANGANESE ENHANCED NUCLEAR MAGNETIC RESONANCE IMAGING; NASAL LAVAGE; TIME; TRANSGENIC MOUSE; AGE; ANIMAL; BRAIN; DISEASE MODEL; GENETICS; IMAGE PROCESSING; METABOLISM; MUTATION; NERVE FIBER; OLFACTORY SYSTEM; PATHOLOGY; PHYSIOLOGY;

AGE FACTORS; ANIMALS; AXONAL TRANSPORT; AXONS; BRAIN; DISEASE MODELS, ANIMAL; FRONTOTEMPORAL DEMENTIA; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MICE; MICE, TRANSGENIC; MUTATION; OLFACTORY MARKER PROTEIN; OLFACTORY PATHWAYS; TAU PROTEINS; TIME FACTORS;

EID: 84899537660     PISSN: None     EISSN: 22131582     Source Type: Journal    
DOI: 10.1016/j.nicl.2014.02.005     Document Type: Article

References (54)

1. M.R. Akins, and C.A. Greer Cytoskeletal organization of the developing mouse olfactory nerve layer J. Comp. Neurol. 494 2006 358 367 (Pubitemid 41798092)
2. J. Avila, J.J. Lucas, M. Pérez, and F. Hernández Role of tau protein in both physiological and pathological conditions Physiol. Rev. 84 2004 361 384 (Pubitemid 38365487)
3. D.M. Barten, P. Fanara, C. Andorfer, N. Hoque, P.Y.A. Wong, K.H. Husted, G.W. Cadelina, L.B. DeCarr, L. Yang, V. Liu, C. Fessler, J. Protassio, T. Riff, H. Turner, C.G. Janus, S. Sankaranarayanan, C. Polson, J.E. Meredith, G. Gray, A. Hanna, R.E. Olson, S.-H. Kim, G.D. Vite, F.Y. Lee, and C.F. Albright Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027 J. Neurosci. 32 2012 7137 7145
4. E.L. Bearer HSV, axonal transport and Alzheimer's disease: in vitro and in vivo evidence for causal relationships Futur. Virol. 7 2012 885 899
5. Z. Berger, H. Roder, A. Hanna, A. Carlson, V. Rangachari, M. Yue, Z. Wszolek, K. Ashe, J. Knight, D. Dickson, C. Andorfer, T.L. Rosenberry, J. Lewis, M. Hutton, and C. Janus Accumulation of pathological tau species and memory loss in a conditional model of tauopathy J. Neurosci. 27 2007 3650 3662 (Pubitemid 46557687)
6. A.M. Bertrand, D. Hoang, U.Z. Khan, and Y. Wadghiri From axonal transport to mitochondrial trafficking: what can we learn from manganese-enhanced MRI studies in mouse models of Alzheimer's disease? Curr. Med. Imaging Rev. 7 2011 16 27
7. A. Bertrand, U. Khan, D.M. Hoang, D.S. Novikov, P. Krishnamurthy, H.B. RajamohamedSait, B.W. Little, E.M. Sigurdsson, and Y.Z. Wadghiri Non-invasive, in vivo monitoring of neuronal transport impairment in a mouse model of tauopathy using MEMRI NeuroImage 64 2013 693 702
8. T.D. Bird, D. Nochlin, P. Poorkaj, M. Cherrier, J. Kaye, H. Payami, E. Peskind, T.H. Lampe, E. Nemens, P.J. Boyer, and G.D. Schellenberg A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L) Brain 122 1999 741 756 (Pubitemid 29158780)
9. M.J. Calkins, and P.H. Reddy Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons Biochim. Biophys. Acta 1812 2011 507 513
10. E. Chevalier-Larsen, and E.L.F. Holzbaur Axonal transport and neurodegenerative disease Biochim. Biophys. Acta (BBA) - Mol. Basis Dis. 1762 2006 1094 1108 (Pubitemid 44750577)
11. B. Combs, and T.C. Gamblin FTDP-17 tau mutations induce distinct effects on aggregation and microtubule interactions Biochemistry (Mosc) 51 2012 8597 8607
12. D.J. Cross, J.A. Flexman, Y. Anzai, K.R. Maravilla, and S. Minoshima Age-related decrease in axonal transport measured by MR imaging in vivo NeuroImage 39 2008 915 926
13. D.C. Davies, J.W. Brooks, and D.A. Lewis Axonal loss from the olfactory tracts in Alzheimer's disease Neurobiol. Aging 14 1993 353 357 (Pubitemid 23214702)
14. P.A. Fu-Hua Wang, Paulina Appelkvist, Tomas Klason, Olle Gissberg, Anna Bogstedt, Kristina Eliason, Stefan Martinsson, Sveinn Briem, Anders Andersson, A. Sandra, G. Visser, Magnus Ivarsson, Mattias Lindberg, Karin Agerman, and Johan Sandin Decreased axonal transport rates in the Tg2576 APP transgenic mouse: improvement with the gamma-secretase inhibitor MRK-560 as detected by manganese-enhanced MRI European Journal of Neuroscience 36 9 2012 3165 3172
15. M. Ghani, D. Pinto, J.H. Lee, Y. Grinberg, C. Sato, D. Moreno, S.W. Scherer, R. Mayeux, P.S. George-Hyslop, and E. Rogaeva Genome-wide survey of large rare copy number variants in Alzheimer's disease among Caribbean Hispanics G3 Genes Genomes Genet. 2 2012 71 78
16. M. Goedert, and M.G. Spillantini Pathogenesis of the tauopathies J. Mol. Neurosci. MN 45 2011 425 431
17. M. Goedert, B. Ghetti, and M.G. Spillantini Frontotemporal dementia: implications for understanding Alzheimer disease Cold Spring Harb. Perspect. Med. 2 2012 a006254
18. K. Hochgräfe, A. Sydow, and E.-M. Mandelkow Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology FEBS J 280 18 2013 4371 4381
19. B.R. Hoover, M.N. Reed, J. Su, R.D. Penrod, L.A. Kotilinek, M.K. Grant, R. Pitstick, G.A. Carlson, L.M. Lanier, L.-L. Yuan, K.H. Ashe, and D. Liao Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration Neuron 68 2010 1067 1081
20. E.M. Ingram, and M.G. Spillantini Tau gene mutations: dissecting the pathogenesis of FTDP-17 Trends Mol. Med. 8 2002 555 562 (Pubitemid 35408213)
21. T. Inoue, T. Majid, and R.G. Pautler Manganese enhanced MRI (MEMRI): neurophysiological applications Rev. Neurosci. 22 2011 675 694
22. T. Ishihara, M. Hong, B. Zhang, Y. Nakagawa, M.K. Lee, J.Q. Trojanowski, and V.M. Lee Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform Neuron 24 1999 751 762
23. C.M. Karch, A.T. Jeng, and A.M. Goate Extracellular Tau levels are influenced by variability in Tau that is associated with tauopathies J. Biol. Chem. 287 2012 42751 42762
24. J. Kim, I.-Y. Choi, M.L. Michaelis, and P. Lee Quantitative in vivo measurement of early axonal transport deficits in a triple transgenic mouse model of Alzheimer's disease using manganese-enhanced MRI NeuroImage 56 2011 1286 1292
25. I. Kim,Choi, M. Michaelis, and S. Lee Early Impaired Axonal Transport in a Triple Transgenic Mouse Model of Alzheimer's Disease 17 2009 (540)
26. K.J. Kopeikina, G.A. Carlson, R. Pitstick, A.E. Ludvigson, A. Peters, J.I. Luebke, R.M. Koffie, M.P. Frosch, B.T. Hyman, and T.L. Spires-Jones Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain Am. J. Pathol. 179 2011 2071 2082
27. C.A. Lasagna-Reeves, D.L. Castillo-Carranza, U. Sengupta, M.J. Guerrero-Munoz, T. Kiritoshi, V. Neugebauer, G.R. Jackson, and R. Kayed Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau Sci. Rep. 2 2012
28. N. Liu Regional distribution of protein kinases in normal and odor-deprived mouse olfactory bulbs Chem. Senses 25 2000 401 406 (Pubitemid 30623838)
29. A.E. Ludvigson, J.I. Luebke, J. Lewis, and A. Peters Structural abnormalities in the cortex of the rTg4510 mouse model of tauopathy: a light and electron microscopy study Brain Struct. Funct. 216 2011 31 42
30. C.A. Massaad, S.K. Amin, L. Hu, Y. Mei, E. Klann, and R.G. Pautler Mitochondrial superoxide contributes to blood flow and axonal transport deficits in the Tg2576 mouse model of Alzheimer's disease PLoS ONE 5 2010 e10561
31. S. Millecamps, and J.-P. Julien Axonal transport deficits and neurodegenerative diseases Nat. Rev. Neurosci. 14 2013 161 176
32. P.D. Perez, G. Hall, T. Kimura, Y. Ren, R.M. Bailey, J. Lewis, M. Febo, and N. Sahara In vivo functional brain mapping in a conditional mouse model of human tauopathy (tau(P301L)) reveals reduced neural activity in memory formation structures Mol. Neurodegener. 8 2013 9
33. Reddy, P.H.; Tripathi, R.; Troung, Q.; Tirumala, Reddy, T.P.; Anekonda, V.; Shirendeb, U.P.; Calkins, M.J.; Reddy, A.P.; Mao, P.; Manczak, M.; n.d. Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. Biochim. Biophys. Acta BBA - Mol. Basis Dis.
34. K. SantaCruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton, and K.H. Ashe Tau suppression in a neurodegenerative mouse model improves memory function Science 309 2005 476 481 (Pubitemid 40994688)
35. A. Sbarbati, L. Calderan, E. Nicolato, P. Marzola, E. Lunati, B. Donatella, P. Bernardi, and F. Osculati Magnetic resonance imaging of the rat Harderian gland J. Anat. 201 2002 231 238
36. K.L. Schulz, A. Eckert, V. Rhein, S. Mai, W. Haase, A.S. Reichert, M. Jendrach, W.E. Müller, and K. Leuner A new link to mitochondrial impairment in tauopathies Mol. Neurobiol. 46 2012 205 216
37. P.E. Seamster, M. Loewenberg, J. Pascal, A. Chauviere, A. Gonzales, V. Cristini, and E.L. Bearer Quantitative measurements and modeling of cargo-motor interactions during fast transport in the living axon Phys. Biol. 9 2012 055005
38. F. Serrano, M. Deshazer, K.D.B. Smith, J.S. Ananta, L.J. Wilson, and R.G. Pautler Assessing transneuronal dysfunction utilizing manganese-enhanced MRI (MEMRI) Magn. Reson. Med. 60 2008 169 175 (Pubitemid 351956621)
39. C.A. Shaw, Y. Li, J. Wiszniewska, S. Chasse, S.N.Y. Zaidi, W. Jin, B. Dawson, K. Wilhelmsen, J.R. Lupski, J.W. Belmont, R.S. Doody, and K. Szigeti Olfactory copy number association with age at onset of Alzheimer disease Neurology 76 2011 1302 1309
40. A.C. Silva, J.H. Lee, I. Aoki, and A.P. Koretsky Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations NMR Biomed. 17 2004 532 543 (Pubitemid 40124779)
41. K.D.B. Smith, V. Kallhoff, H. Zheng, and R.G. Pautler In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease NeuroImage 35 2007 1401 1408 (Pubitemid 46561352)
42. K.D.B. Smith, E. Peethumnongsin, H. Lin, H. Zheng, and R.G. Pautler Increased human wildtype tau attenuates axonal transport deficits caused by loss of APP in mouse models Magn. Reson. Insights 4 2010 11 18
43. J.S. Snowden, D. Neary, and D.M.A. Mann Frontotemporal dementia Br. J. Psychiatry 180 2002 140 143 (Pubitemid 34142785)
44. G.B. Stokin, and L.S.B. Goldstein Axonal transport and Alzheimer's disease Annu. Rev. Biochem. 75 2006 607 627 (Pubitemid 44118045)
45. S. Swaminathan, M.J. Huentelman, J.J. Corneveaux, A.J. Myers, K.M. Faber, T. Foroud, R. Mayeux, L. Shen, S. Kim, M. Turk, J. Hardy, E.M. Reiman, A.J. Saykin, and the Alzheimer's Disease Neuroimaging Initiative (ADNI) and the NIA-LOAD/NCRAD Family Study Group Analysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals PLoS ONE 7 2012 e50640
46. P.A. Trimmer, and M.K. Borland Differentiated Alzheimer's disease transmitochondrial cybrid cell lines exhibit reduced organelle movement Antioxid. Redox Signal. 7 2005 1101 1109 (Pubitemid 41232506)
47. D.V. Venkitaramani, S. Paul, Y. Zhang, P. Kurup, L. Ding, L. Tressler, M. Allen, R. Sacca, M.R. Picciotto, and P.J. Lombroso Knockout of striatal enriched protein tyrosine phosphatase in mice results in increased ERK1/2 phosphorylation Synap. N Y C 63 2009 69 81
48. Z.K. Wszolek, Y. Tsuboi, B. Ghetti, S. Pickering-Brown, Y. Baba, and W.P. Cheshire Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) Orphanet J. Rare Dis. 1 2006 30
49. A. Yuan, A. Kumar, C. Peterhoff, K. Duff, and R.A. Nixon Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice J. Neurosci. Off. J. Soc. Neurosci. 28 2008 1682
50. M. Yue, A. Hanna, J. Wilson, H. Roder, and C. Janus Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy Neurobiol. Aging 32 2011 590 603
51. B. Zhang, M. Higuchi, Y. Yoshiyama, T. Ishihara, M.S. Forman, D. Martinez, S. Joyce, J.Q. Trojanowski, and V.M.-Y. Lee Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy J. Neurosci. Off. J. Soc. Neurosci. 24 2004 4657 4667 (Pubitemid 38656621)
52. B. Zhang, A. Maiti, S. Shively, F. Lakhani, G. McDonald-Jones, J. Bruce, E.B. Lee, S.X. Xie, S. Joyce, C. Li, P.M. Toleikis, V.M.-Y. Lee, and J.Q. Trojanowski Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model Proc. Natl. Acad. Sci. U. S. A. 102 2005 227 231 (Pubitemid 40094457)
53. Y. Zhang, H.-M. Zhang, Y. Shi, M. Lustgarten, Y. Li, W. Qi, B.-X. Zhang, and H. Van Remmen Loss of manganese superoxide dismutase leads to abnormal growth and signal transduction in mouse embryonic fibroblasts Free Radic. Biol. Med. 49 2010 1255 1262
54. C. Zwingmann, D. Leibfritz, and A.S. Hazell Brain energy metabolism in a sub-acute rat model of manganese neurotoxicity: an ex vivo nuclear magnetic resonance study using [1-13C]glucose Neurotoxicology 25 2004 573 587 (Pubitemid 38739114)